{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "16747775", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20191005", "reporttype": "1", "serious": "1", "seriousnessother": "1", "receivedateformat": "102", "receivedate": "20190827", "receiptdateformat": "102", "receiptdate": "20190827", "fulfillexpeditecriteria": "2", "companynumb": "US-CELGENEUS-USA-20190808229", "duplicate": "1", "reportduplicate": { "duplicatesource": "CELGENE", "duplicatenumb": "US-CELGENEUS-USA-20190808229" }, "primarysource": { "reportercountry": "US", "qualification": "2" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientweight": "66.24", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "22.0", "reactionmeddrapt": "Cataract", "reactionoutcome": "2" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "ATIVAN", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "LORAZEPAM" }, "openfda": { "application_number": [ "NDA017794", "NDA018140" ], "brand_name": [ "ATIVAN" ], "generic_name": [ "LORAZEPAM" ], "manufacturer_name": [ "Bausch Health US LLC", "Hikma Pharmaceuticals USA Inc." ], "product_ndc": [ "0187-0063", "0187-0064", "0187-0065", "0641-6000", "0641-6003", "0641-6002", "0641-6001" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL", "INTRAMUSCULAR", "INTRAVENOUS" ], "substance_name": [ "LORAZEPAM" ], "rxcui": [ "104719", "197900", "197901", "197902", "206821", "206828", "206819", "206820", "238100", "238101", "1665188", "1665190", "1665326", "1665327" ], "spl_id": [ "93bdf2de-1222-44a4-b4d5-2280f9ce58d8", "209b0091-c890-4f69-a693-d0594c2606fe" ], "spl_set_id": [ "89057c93-8155-4040-acec-64e877bd2b4c", "5fc0e987-61c9-40c4-b0d5-fcea07c8733e" ], "package_ndc": [ "0187-0063-01", "0187-0063-50", "0187-0063-10", "0187-0064-01", "0187-0064-50", "0187-0064-10", "0187-0065-01", "0187-0065-50", "0187-0065-10", "0641-6003-01", "0641-6003-25", "0641-6002-01", "0641-6002-10", "0641-6001-01", "0641-6001-25", "0641-6000-01", "0641-6000-10" ], "nui": [ "N0000175694", "M0002356" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "unii": [ "O26FZP769L" ] } }, { "drugcharacterization": "1", "medicinalproduct": "REVLIMID", "drugbatchnumb": "A2869B", "drugauthorizationnumb": "021880", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "10 MILLIGRAM", "drugdosageform": "CAPSULES", "drugadministrationroute": "048", "drugindication": "PLASMA CELL MYELOMA", "drugstartdateformat": "102", "drugstartdate": "20170619", "actiondrug": "4", "drugrecurreadministration": "3", "activesubstance": { "activesubstancename": "LENALIDOMIDE" }, "openfda": { "application_number": [ "NDA021880" ], "brand_name": [ "REVLIMID" ], "generic_name": [ "LENALIDOMIDE" ], "manufacturer_name": [ "Celgene Corporation" ], "product_ndc": [ "59572-402", "59572-405", "59572-410", "59572-415", "59572-420", "59572-425" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LENALIDOMIDE" ], "rxcui": [ "602910", "602912", "616114", "616116", "643712", "643714", "643720", "643722", "1242231", "1242233", "1428947", "1429367" ], "spl_id": [ "9329fd28-b848-4013-92e0-a68270328336" ], "spl_set_id": [ "5fa97bf5-28a2-48f1-8955-f56012d296be" ], "package_ndc": [ "59572-402-28", "59572-402-00", "59572-405-28", "59572-405-00", "59572-410-28", "59572-410-00", "59572-415-21", "59572-415-00", "59572-420-21", "59572-420-00", "59572-425-21", "59572-425-00" ], "nui": [ "N0000184014" ], "pharm_class_epc": [ "Thalidomide Analog [EPC]" ], "unii": [ "F0P408N6V4" ] } }, { "drugcharacterization": "2", "medicinalproduct": "MARINOL", "drugdosageform": "CAPSULES", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "DRONABINOL" }, "openfda": { "application_number": [ "NDA018651" ], "brand_name": [ "MARINOL" ], "generic_name": [ "DRONABINOL" ], "manufacturer_name": [ "ThePharmaNetwork, LLC" ], "product_ndc": [ "53097-568", "53097-569", "53097-570", "53097-571", "53097-572", "53097-573" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DRONABINOL" ], "rxcui": [ "197634", "197635", "197636", "205641", "205642", "205645" ], "spl_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48" ], "spl_set_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "d0efeeec-640d-43c3-8f0a-d31324a11c68" ], "package_ndc": [ "53097-568-60", "53097-569-60", "53097-570-60", "53097-571-60", "53097-572-60", "53097-573-60" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "7J8897W37S" ] } }, { "drugcharacterization": "2", "medicinalproduct": "CALCIUM D", "drugdosagetext": "500MG-1000", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "CALCIUM\\VITAMIN D" } }, { "drugcharacterization": "2", "medicinalproduct": "VALACYCLOVIR HYDROCHLORIDE.", "drugdosageform": "UNKNOWN", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "VALACYCLOVIR HYDROCHLORIDE" }, "openfda": { "application_number": [ "NDA020487", "ANDA090682", "ANDA078518", "ANDA201506", "ANDA209553", "ANDA079012" ], "brand_name": [ "VALTREX", "VALACYCLOVIR HYDROCHLORIDE", "VALACYCLOVIR" ], "generic_name": [ "VALACYCLOVIR HYDROCHLORIDE", "VALACYCLOVIR" ], "manufacturer_name": [ "GlaxoSmithKline LLC", "Aurobindo Pharma Limited", "NorthStar Rx LLC", "Mylan Pharmaceuticals Inc.", "Jubilant Cadista Pharmaceuticals Inc.", "Yiling Pharmaceutical, Inc.", "TIME CAP LABORATORIES, INC.", "Rising Pharma Holdings, Inc." ], "product_ndc": [ "0173-0565", "0173-0933", "65862-448", "65862-449", "16714-697", "16714-698", "0378-4275", "0378-4276", "59746-324", "59746-325", "69117-0011", "69117-0010", "49483-690", "49483-691", "57237-042", "57237-043" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "VALACYCLOVIR HYDROCHLORIDE" ], "rxcui": [ "108780", "212448", "313564", "313565" ], "spl_id": [ "861c5801-9c12-4a6b-9bf4-aacb183a58b0", "aecf12c1-9094-48b6-8cb0-fcace52e191a", "6b2156c4-0d81-4c53-b497-85ed8d7656d0", "7de6158d-06ad-4500-a485-dafc151c16ff", "40211dd2-c21e-45a4-a8d4-04febf925f52", "47237b45-ce93-292b-e063-6394a90a1ab5", "c715d9f2-9fe1-0bdd-e053-2a95a90aecf2", "a9ee543a-9c63-46df-99f9-cd085ce08bee" ], "spl_set_id": [ "f8e0d8f8-cb73-4206-a484-88f5c4fbd719", "f5cfb61e-d971-4a9c-b9ef-4f3368fe02f5", "4acf51de-26f7-42b2-8acc-61b800627ef3", "56bf715d-8280-4557-9f98-9693932199e5", "3277c17e-f953-2b0a-fe0a-4f5d1aeace9d", "f3ee4017-a4fc-475d-a49b-b39168ec5966", "c33a2a36-16d3-4a35-e053-2995a90af240", "8d1645c0-fd03-4992-9372-98026a26b3af" ], "package_ndc": [ "0173-0933-08", "0173-0933-10", "0173-0565-04", "0173-0565-10", "65862-448-30", "65862-448-90", "65862-448-01", "65862-448-05", "65862-448-35", "65862-448-10", "65862-449-30", "65862-449-90", "65862-449-01", "65862-449-05", "65862-449-15", "16714-698-01", "16714-698-03", "16714-698-02", "16714-697-01", "16714-697-03", "16714-697-02", "16714-697-04", "0378-4275-93", "0378-4275-77", "0378-4276-93", "0378-4276-77", "59746-324-10", "59746-324-30", "59746-324-90", "59746-324-01", "59746-324-37", "59746-324-47", "59746-325-10", "59746-325-30", "59746-325-90", "59746-325-01", "59746-325-37", "59746-325-47", "69117-0010-1", "69117-0010-2", "69117-0010-3", "69117-0011-1", "69117-0011-2", "69117-0011-3", "49483-690-03", "49483-690-41", "49483-690-50", "49483-690-04", "49483-691-03", "49483-691-50", "49483-691-04", "49483-691-01", "57237-042-30", "57237-042-90", "57237-042-05", "57237-043-30", "57237-043-90", "57237-043-05" ], "unii": [ "G447S0T1VC" ] } }, { "drugcharacterization": "1", "medicinalproduct": "REVLIMID", "drugbatchnumb": "A2869B", "drugauthorizationnumb": "021880", "drugstructuredosagenumb": "5", "drugstructuredosageunit": "003", "drugdosagetext": "5 MILLIGRAM", "drugdosageform": "CAPSULES", "drugadministrationroute": "048", "drugstartdateformat": "610", "drugstartdate": "201709", "actiondrug": "4", "drugrecurreadministration": "3", "activesubstance": { "activesubstancename": "LENALIDOMIDE" }, "openfda": { "application_number": [ "NDA021880" ], "brand_name": [ "REVLIMID" ], "generic_name": [ "LENALIDOMIDE" ], "manufacturer_name": [ "Celgene Corporation" ], "product_ndc": [ "59572-402", "59572-405", "59572-410", "59572-415", "59572-420", "59572-425" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LENALIDOMIDE" ], "rxcui": [ "602910", "602912", "616114", "616116", "643712", "643714", "643720", "643722", "1242231", "1242233", "1428947", "1429367" ], "spl_id": [ "9329fd28-b848-4013-92e0-a68270328336" ], "spl_set_id": [ "5fa97bf5-28a2-48f1-8955-f56012d296be" ], "package_ndc": [ "59572-402-28", "59572-402-00", "59572-405-28", "59572-405-00", "59572-410-28", "59572-410-00", "59572-415-21", "59572-415-00", "59572-420-21", "59572-420-00", "59572-425-21", "59572-425-00" ], "nui": [ "N0000184014" ], "pharm_class_epc": [ "Thalidomide Analog [EPC]" ], "unii": [ "F0P408N6V4" ] } }, { "drugcharacterization": "2", "medicinalproduct": "GLUTAMINE", "drugdosageform": "POWDER", "drugadministrationroute": "065", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "GLUTAMINE" }, "openfda": { "application_number": [ "NDA208587" ], "brand_name": [ "ENDARI" ], "generic_name": [ "GLUTAMINE" ], "manufacturer_name": [ "Emmaus Medical, Inc." ], "product_ndc": [ "42457-420" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "GLUTAMINE" ], "rxcui": [ "1869684", "1928941" ], "spl_id": [ "10f5d160-6687-44d5-a607-6bf69a7312b6" ], "spl_set_id": [ "d5a783f4-12ef-4326-8faa-40018e45ba3b" ], "package_ndc": [ "42457-420-01", "42457-420-60" ], "nui": [ "N0000175780", "M0000922" ], "pharm_class_epc": [ "Amino Acid [EPC]" ], "pharm_class_cs": [ "Amino Acids [CS]" ], "unii": [ "0RH81L854J" ] } }, { "drugcharacterization": "2", "medicinalproduct": "REMERON", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "MIRTAZAPINE" }, "openfda": { "application_number": [ "NDA020415" ], "brand_name": [ "REMERON" ], "generic_name": [ "MIRTAZAPINE" ], "manufacturer_name": [ "Organon LLC" ], "product_ndc": [ "78206-160", "78206-161", "78206-156", "78206-158", "78206-159" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "MIRTAZAPINE" ], "rxcui": [ "211322", "211323", "283406", "283407", "283485", "311725", "314111", "752869", "752870", "752871" ], "spl_id": [ "8b121c7c-9bcd-4504-b789-3f551a0fe514" ], "spl_set_id": [ "98ad1917-a094-44f5-a28f-a64a8cfcd887" ], "package_ndc": [ "78206-160-01", "78206-161-01", "78206-156-99", "78206-156-01", "78206-158-99", "78206-158-01", "78206-159-99", "78206-159-01" ], "unii": [ "A051Q2099Q" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ZINC-15", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION" }, { "drugcharacterization": "2", "medicinalproduct": "PREVACID", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "LANSOPRAZOLE" }, "openfda": { "application_number": [ "NDA020406" ], "brand_name": [ "PREVACID" ], "generic_name": [ "LANSOPRAZOLE" ], "manufacturer_name": [ "Takeda Pharmaceuticals America, Inc." ], "product_ndc": [ "64764-046", "64764-543", "64764-544" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LANSOPRAZOLE" ], "rxcui": [ "206205", "206206", "311277", "351260", "351261", "866152" ], "spl_id": [ "45f1d5ff-d884-4e40-a16c-313a4e21e32c" ], "spl_set_id": [ "71ba78cb-7e46-43eb-9425-fa130f537f84" ], "package_ndc": [ "64764-046-13", "64764-046-19", "64764-046-11", "64764-046-06", "64764-543-30", "64764-543-11", "64764-543-05", "64764-544-30", "64764-544-11", "64764-544-05" ], "nui": [ "N0000175525", "N0000000147", "N0000009724" ], "pharm_class_epc": [ "Proton Pump Inhibitor [EPC]" ], "pharm_class_moa": [ "Proton Pump Inhibitors [MoA]" ], "pharm_class_pe": [ "Inhibition Gastric Acid Secretion [PE]" ], "unii": [ "0K5C5T2QPG" ] } }, { "drugcharacterization": "1", "medicinalproduct": "REVLIMID", "drugbatchnumb": "A2869B", "drugauthorizationnumb": "021880", "drugstructuredosagenumb": "25", "drugstructuredosageunit": "003", "drugseparatedosagenumb": "1", "drugintervaldosageunitnumb": "1", "drugintervaldosagedefinition": "804", "drugdosagetext": "25 MILLIGRAM", "drugdosageform": "CAPSULES", "drugadministrationroute": "048", "drugindication": "PLASMA CELL LEUKAEMIA", "drugstartdateformat": "610", "drugstartdate": "201612", "actiondrug": "4", "drugrecurreadministration": "3", "activesubstance": { "activesubstancename": "LENALIDOMIDE" }, "openfda": { "application_number": [ "NDA021880" ], "brand_name": [ "REVLIMID" ], "generic_name": [ "LENALIDOMIDE" ], "manufacturer_name": [ "Celgene Corporation" ], "product_ndc": [ "59572-402", "59572-405", "59572-410", "59572-415", "59572-420", "59572-425" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LENALIDOMIDE" ], "rxcui": [ "602910", "602912", "616114", "616116", "643712", "643714", "643720", "643722", "1242231", "1242233", "1428947", "1429367" ], "spl_id": [ "9329fd28-b848-4013-92e0-a68270328336" ], "spl_set_id": [ "5fa97bf5-28a2-48f1-8955-f56012d296be" ], "package_ndc": [ "59572-402-28", "59572-402-00", "59572-405-28", "59572-405-00", "59572-410-28", "59572-410-00", "59572-415-21", "59572-415-00", "59572-420-21", "59572-420-00", "59572-425-21", "59572-425-00" ], "nui": [ "N0000184014" ], "pharm_class_epc": [ "Thalidomide Analog [EPC]" ], "unii": [ "F0P408N6V4" ] } }, { "drugcharacterization": "2", "medicinalproduct": "KLONOPIN", "drugdosageform": "TABLETS", "drugadministrationroute": "048", "drugindication": "PRODUCT USED FOR UNKNOWN INDICATION", "activesubstance": { "activesubstancename": "CLONAZEPAM" }, "openfda": { "application_number": [ "NDA017533" ], "brand_name": [ "KLONOPIN" ], "generic_name": [ "CLONAZEPAM" ], "manufacturer_name": [ "H2-Pharma, LLC" ], "product_ndc": [ "61269-605", "61269-610", "61269-620" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CLONAZEPAM" ], "rxcui": [ "197527", "197528", "197529", "206157", "206159", "206160" ], "spl_id": [ "63cfdab9-fb3d-4c2b-bf88-8ba841dba839" ], "spl_set_id": [ "cfa0d79a-843c-4b88-95a1-e9511d649ca1" ], "package_ndc": [ "61269-605-10", "61269-610-10", "61269-620-10" ], "nui": [ "N0000175694", "M0002356" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "unii": [ "5PE9FDE8GB" ] } } ] } } ] }